Turning back the clock: the increase in bilateral mastectomies

Article Type

Changed

Thu, 12/15/2022 - 18:07

Display Headline

Author(s)

When Bernard Fisher of National Surgical Adjuvant Breast and Bowel Project and George Crile Jr of the Cleveland Clinic initiated the conversation about breast cancer patients opting for breast preservation over radical surgery and achieving the same outcomes as those who opted for mastectomy, it was a game-changing concept. They were considered pariahs by their surgical peers, the dominating Halstedian surgeons. But when Fisher and his colleagues published fndings¹ that showed equal efficacy for lumpectomy and mastectomy, the world took notice. Surgeons and patients were quick embrace the evidence, and that dramatic change in the approach to treatment continued until 2004, when we started seeing a steady increase in the mastectomy rate, and especially prophylactic mastectomy.

Click on the PDF icon at the top of this introduction to read the full article.

Article PDF

JCSO_Oct_2014_345_Abraham.pdf

Issue

The Journal of Community and Supportive Oncology - 12(10)

Publications

The Journal of Community and Supportive Oncology

MDedge Hematology and Oncology

Breast Cancer ICYMI

Topics

Breast Cancer

Page Number

345-346

Legacy Keywords

breast cancer, bilateral mastectomy, breast preservation, prophylactic mastectomy, breast-conserving surgery, unilateral breast cancer

Sections

From the Editor

Author(s)

Jame Abraham

Author(s)

Jame Abraham

Article PDF

JCSO_Oct_2014_345_Abraham.pdf

Article PDF

JCSO_Oct_2014_345_Abraham.pdf

When Bernard Fisher of National Surgical Adjuvant Breast and Bowel Project and George Crile Jr of the Cleveland Clinic initiated the conversation about breast cancer patients opting for breast preservation over radical surgery and achieving the same outcomes as those who opted for mastectomy, it was a game-changing concept. They were considered pariahs by their surgical peers, the dominating Halstedian surgeons. But when Fisher and his colleagues published fndings¹ that showed equal efficacy for lumpectomy and mastectomy, the world took notice. Surgeons and patients were quick embrace the evidence, and that dramatic change in the approach to treatment continued until 2004, when we started seeing a steady increase in the mastectomy rate, and especially prophylactic mastectomy.

Click on the PDF icon at the top of this introduction to read the full article.

When Bernard Fisher of National Surgical Adjuvant Breast and Bowel Project and George Crile Jr of the Cleveland Clinic initiated the conversation about breast cancer patients opting for breast preservation over radical surgery and achieving the same outcomes as those who opted for mastectomy, it was a game-changing concept. They were considered pariahs by their surgical peers, the dominating Halstedian surgeons. But when Fisher and his colleagues published fndings¹ that showed equal efficacy for lumpectomy and mastectomy, the world took notice. Surgeons and patients were quick embrace the evidence, and that dramatic change in the approach to treatment continued until 2004, when we started seeing a steady increase in the mastectomy rate, and especially prophylactic mastectomy.

Click on the PDF icon at the top of this introduction to read the full article.

Issue

The Journal of Community and Supportive Oncology - 12(10)

Issue

The Journal of Community and Supportive Oncology - 12(10)

Page Number

345-346

Page Number

345-346

Publications

The Journal of Community and Supportive Oncology

MDedge Hematology and Oncology